Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil
- PMID: 33341806
- PMCID: PMC7801990
- DOI: 10.1159/000513425
Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil
Abstract
Background: Critically ill patients with COVID-19 may develop multiple organ dysfunction syndrome, including acute kidney injury (AKI). We report the incidence, risk factors, associations, and outcomes of AKI and renal replacement therapy (RRT) in critically ill COVID-19 patients.
Methods: We performed a retrospective cohort study of adult patients with COVID-19 diagnosis admitted to the intensive care unit (ICU) between March 2020 and May 2020. Multivariable logistic regression analysis was applied to identify risk factors for the development of AKI and use of RRT. The primary outcome was 60-day mortality after ICU admission.
Results: 101 (50.2%) patients developed AKI (72% on the first day of invasive mechanical ventilation [IMV]), and thirty-four (17%) required RRT. Risk factors for AKI included higher baseline Cr (OR 2.50 [1.33-4.69], p = 0.005), diuretic use (OR 4.14 [1.27-13.49], p = 0.019), and IMV (OR 7.60 [1.37-42.05], p = 0.020). A higher C-reactive protein level was an additional risk factor for RRT (OR 2.12 [1.16-4.33], p = 0.023). Overall 60-day mortality was 14.4% {23.8% (n = 24) in the AKI group versus 5% (n = 5) in the non-AKI group (HR 2.79 [1.04-7.49], p = 0.040); and 35.3% (n = 12) in the RRT group versus 10.2% (n = 17) in the non-RRT group, respectively (HR 2.21 [1.01-4.85], p = 0.047)}.
Conclusions: AKI was common among critically ill COVID-19 patients and occurred early in association with IMV. One in 6 AKI patients received RRT and 1 in 3 patients treated with RRT died in hospital. These findings provide important prognostic information for clinicians caring for these patients.
Keywords: Acute kidney injury; COVID-19; Continuous renal replacement therapy; Dialysis; Intensive care unit; Severe acute respiratory syndrome coronavirus 2.
© 2020 S. Karger AG, Basel.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures
Similar articles
-
Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study.BMC Nephrol. 2021 Mar 15;22(1):92. doi: 10.1186/s12882-021-02296-z. BMC Nephrol. 2021. PMID: 33722189 Free PMC article.
-
Epidemiology and Outcomes of Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome: A Multicenter Retrospective Study.Blood Purif. 2021;50(4-5):499-505. doi: 10.1159/000512371. Epub 2020 Dec 8. Blood Purif. 2021. PMID: 33291098 Free PMC article.
-
Outcomes of renal replacement therapy in the critically ill with COVID-19.Med Intensiva (Engl Ed). 2021 Aug-Sep;45(6):325-331. doi: 10.1016/j.medine.2021.02.006. Med Intensiva (Engl Ed). 2021. PMID: 34294231 Free PMC article.
-
Critical analysis of acute kidney injury in pediatric COVID-19 patients in the intensive care unit.Pediatr Nephrol. 2021 Sep;36(9):2627-2638. doi: 10.1007/s00467-021-05084-x. Epub 2021 Apr 29. Pediatr Nephrol. 2021. PMID: 33928439 Free PMC article.
-
Accelerated versus standard initiation of renal replacement therapy for critically ill patients with acute kidney injury: a systematic review and meta-analysis of RCT studies.Crit Care. 2021 Jan 5;25(1):5. doi: 10.1186/s13054-020-03434-z. Crit Care. 2021. PMID: 33402204 Free PMC article.
Cited by
-
Acute kidney injury requiring renal replacement therapy in people with COVID-19 disease in Ontario, Canada: a prospective analysis of risk factors and outcomes.Clin Kidney J. 2021 Nov 27;15(3):507-516. doi: 10.1093/ckj/sfab237. eCollection 2022 Mar. Clin Kidney J. 2021. PMID: 35198157 Free PMC article.
-
Prognostic role of renal replacement therapy among hospitalized patients with heart failure in the Brazilian national public health system.Front Cardiovasc Med. 2023 Aug 23;10:1226481. doi: 10.3389/fcvm.2023.1226481. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37680567 Free PMC article.
-
Application of extracorporeal therapies in critically ill COVID-19 patients.J Zhejiang Univ Sci B. 2021 Sept 15;22(9):701-717. doi: 10.1631/jzus.B2100344. J Zhejiang Univ Sci B. 2021. PMID: 34514751 Free PMC article.
-
Acute kidney injury in hospitalized patients with COVID-19: a retrospective cohort.Crit Care Sci. 2023 Apr-Jun;35(2):236-238. doi: 10.5935/2965-2774.20230428-en. Crit Care Sci. 2023. PMID: 37712816 Free PMC article. No abstract available.
-
Acute Kidney Disease and Mortality in Acute Kidney Injury Patients with COVID-19.J Clin Med. 2021 Oct 6;10(19):4599. doi: 10.3390/jcm10194599. J Clin Med. 2021. PMID: 34640618 Free PMC article.
References
-
- Coronavírus. Ministério da Saúde. Brasília, Brasil. https://www.saude.gov.br/ Accessed 2020 Jul 20.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials